Zu L - Search Results

1

Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement.

Zhou N, Li T, Liang M, Ren F, Ni H, Liu W, Shi T, Xu D, Chen Q, Yu H, Song Z, Zu L, Li S, Xu S. Zhou N, et al. Among authors: zu l. Front Oncol. 2022 Feb 10;12:848779. doi: 10.3389/fonc.2022.848779. eCollection 2022. Front Oncol. 2022. PMID: 35223529 Free PMC article.

2

Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential.

Liu Z, Xu S, Li L, Zhong X, Chen C, Fan Y, Shen W, Zu L, Xue F, Wang M, Zhou Q. Liu Z, et al. Among authors: zu l. Thorac Cancer. 2019 May;10(5):1111-1128. doi: 10.1111/1759-7714.13052. Epub 2019 Apr 4. Thorac Cancer. 2019. PMID: 30950202 Free PMC article.

3

Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer.

Zhu G, Ren D, Lei X, Shi R, Zhu S, Zhou N, Zu L, Mello RA, Chen J, Xu S. Zhu G, et al. Among authors: zu l. Cancers (Basel). 2021 Mar 19;13(6):1397. doi: 10.3390/cancers13061397. Cancers (Basel). 2021. PMID: 33808631 Free PMC article.

4

Prognostic value of ferroptosis-related genes in patients with lung adenocarcinoma.

Zhu G, Huang H, Xu S, Shi R, Gao Z, Lei X, Zhu S, Zhou N, Zu L, Mello RA, Chen J, Xu S. Zhu G, et al. Among authors: zu l. Thorac Cancer. 2021 Jun;12(12):1890-1899. doi: 10.1111/1759-7714.13998. Epub 2021 May 12. Thorac Cancer. 2021. PMID: 33979897 Free PMC article.

5

Complete disease remission in a TP53 and KRAS co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case report.

Zhu S, Zhao S, Zhang Q, Li S, Ren D, Ren F, Zu L, Wang Y, Lei X, Zhou N, Shi T, Xu D, Chen G, Lim WT, Giusti R, Wu AJ, Xu S. Zhu S, et al. Among authors: zu l. Transl Lung Cancer Res. 2021 May;10(5):2298-2305. doi: 10.21037/tlcr-21-380. Transl Lung Cancer Res. 2021. PMID: 34164277 Free PMC article.

6

Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors.

Xu S, Li X, Zhang H, Zu L, Yang L, Shi T, Zhu S, Lei X, Song Z, Chen J. Xu S, et al. Among authors: zu l. Front Oncol. 2021 Jul 8;11:667148. doi: 10.3389/fonc.2021.667148. eCollection 2021. Front Oncol. 2021. PMID: 34307137 Free PMC article.

7

LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma.

Jin X, Chen L, Zhou N, Ni H, Zu L, He J, Yang L, Zhu Y, Sun X, Li X, Xu S. Jin X, et al. Among authors: zu l. Front Mol Biosci. 2021 Nov 26;8:711928. doi: 10.3389/fmolb.2021.711928. eCollection 2021. Front Mol Biosci. 2021. PMID: 34901148 Free PMC article.

8

Establishment and characterization of a novel highly malignant lung cancer cell line ZX2021H derived from a metastatic lymph node lesion.

Zu L, Li X, He J, Zhou N, Meng F, Li X, Xu S, Zhang L. Zu L, et al. Thorac Cancer. 2022 Apr;13(8):1199-1210. doi: 10.1111/1759-7714.14385. Epub 2022 Mar 16. Thorac Cancer. 2022. PMID: 35297208 Free PMC article.

9

[The Expression of RTN1 in Lung Adenocarcinoma and  Its Effect on Immune Microenvironment].

Zhu S, Zu L, Xu S. Zhu S, et al. Among authors: zu l. Zhongguo Fei Ai Za Zhi. 2022 Jun 20;25(6):385-395. doi: 10.3779/j.issn.1009-3419.2022.105.02. Zhongguo Fei Ai Za Zhi. 2022. PMID: 35747917 Free PMC article. Chinese.

10

Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm.

Lei X, Zhou N, Zhang H, Li T, Ren F, Zhang B, Li X, Zu L, Song Z, Xu S. Lei X, et al. Among authors: zu l. Cancers (Basel). 2022 Jul 4;14(13):3265. doi: 10.3390/cancers14133265. Cancers (Basel). 2022. PMID: 35805037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters